PACE Interim Impact Report

Medicines Discovery Catapult needs an interim impact report on PACE, a £30 million antimicrobial drug and diagnostics initiative. The report will assess outcomes and long-term impacts at a key point in the five-year programme.

• Closed9 January 2026
• Value£50k
• BuyerMEDICINES DISCOVERY CATAPULT LIMITED
• CategoryBusiness & professional services
• RegionNorth West

You'll want to look if you have experience evaluating research and innovation programmes, particularly in life sciences or medicines development, and can assess programme outcomes against strategic objectives.

Original notice

View on Find a Tender → (opens in a new tab)